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Abstract 
Seven novel imidazole and thiazole derivatives of diphos-type ligands are presented. They are 
of the general structure R2P(CH2)2PR2, where R is imidazol-2-yl (1), 1-methylimidazol-2-yl 
(2), 1-methylbenzimidazol-2-yl (3), 1-methylimidazol-5-yl (4), 2-isopropylimidazol-4(5)-yl 
(5), thiazol-2-yl (6), benzothiazol-2-yl (7), thiazol-4-yl (8) or thiazol-5-yl (9). Syntheses 
involved direct metallation or halogen-metal exchange reactions. Their solubility, especially 
in aqueous solution, is strongly dependent on the nature of the substituents as is their partition 
coefficient logD. The crystal structures of compounds 2, 3, 7a and 9 as well as the structure of 
the rhodium complex [(2)2Rh2Cl2]Cl2 (10) have been determined. 
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1. Introduction 
Undoubtedly, diphosphane ligands play a key role in homogenous catalysis. The rare amino 
acid L-DOPA is synthesised using the rhodium(I) complex [Rh{(R,R)-DiPAMP}(cod)]BF4 of 
the chiral diphosphane (R,R)-DiPAMP for which Knowles received the Nobel price in 2001. 
Especially the development of chiral diphosphanes such as DIOP, Norphos and Chiraphos or 
P-stereogenic ligands as DiPAMP or BisP* has been pursued due to their abilities to induce 
high enantioselectivities.[1, 2] For the use in biphasic catalysis, water-soluble diphosphanes 
were developed. Usually these have charged functional groups as carboxylato, sulfonato or 
phosphonato groups or quaternary ammonium groups. But still, compared to the wide variety 
of diphosphanes used in catalysis, water-soluble diphosphanes are scarce. Beside the 
importance of phosphanes in catalysis, phosphane complexes in medicinal chemistry gain 
more and more attention; For example the Ru(II) complex [(η6-p-cymene)RuCl2(pta)] of the 
water-soluble pta ligand (pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane) has been 
reported to exhibit antibacterial activity[3] and the gold(I) complex [(dppe)2Au]Cl exhibits 
antitumor activity in different cell lines.[4] For the use in biomedical applications the 
(di)phosphane ligands and their complexes have to fulfil certain demands. Not only do they 
need to be water-soluble, but have to exhibit a finely adjusted hydrophilicity / hydrophobicity 
profile, as this determines both their pharmacokinetic and pharmacodynamics. For example, 
clinical trials on [(dppe)2Au]Cl were hampered by high hepato- and cardiotoxicity related to 
the highly hydrophobic nature of this complex.[5, 6] To circumvent the lipophilicity related 
side effects, more hydrophilic diphos complexes have to be developed and one approach is to 
replace the phenyl rings of dppe by pyridine.[7-11] We have developed imidazole-based 
water-soluble phosphane ligands for application as enzyme models and for biomedical 
applications in the past.[12, 13] Based upon our previous findings, we herein report on 
synthetic routes towards diverse imidazolyl as well as thiazolyl substituted diphosphane 
ligands, which should exhibit similar properties concerning their use in biological media. To 
evaluate the new ligands exact hydrophilicity / hydrophobicity profile, their n-octanol/water 
partition coefficients at pH = 7.4 were determined.   
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2. Results and Discussion 
Symmetrical diphosphanes of the diphos-type R2P(CH2)2PR2 were prepared by reaction of 
bis(dichlorophosphino)ethane with nucleophiles. The starting material 
bis(dichlorophosphino)ethane was prepared from ethylene, phosphorus trichloride and white 
phosphorus in an steel autoclave according to the high-pressure procedure of Chatt.[14] While 
it has been reported, that after several runs the autoclave begins to deteriorate,[15] we 
observed corrosion especially of the needle-valves.  
Ligands 2 and 6 were synthesised according procedures for tris(N-methylimidazol-2-
yl)phosphane and tris(thiazol-2-yl)phosphane by Moore and Whitesides.[16] For the 
preparation of 2 bis(dichlorophosphino)ethane was treated with 1-methyl-2-
trimethylsilylimidazole. After lithiation of either N-methylbenzimidazole or thiazole and the 
following reaction with bis(dichlorophosphino)ethane ligands 3 and 6 respectively, were 
obtained in good yields, whereas the reaction of 2-bromothiazole with n-butyl lithium did not 
yield the desired product.  
 
*** PUT FIGURE 1 HERE *** 
Figure 1: Azole-based diphosphane ligands 1 - 9. 
 
Ligands 1 and 5 were prepared starting from the corresponding diethoxymethyl-protected 
imidazoles,[17, 18] which were lithiated using n-butyl lithium and tert.-butyl lithium 
respectively. The lithiated species were reacted with bis(dichlorophosphino)ethane to obtain 
the DEM-protected ligands. Direct deprotection was achieved by refluxing the products in a 
10:1 mixture of aceton/water, from which the analytically pure ligands precipitated upon 
cooling. 
 
*** PUT SCHEME 1 HERE *** 
Scheme 1: Reaction conditions for the preparation of the different 1,2-
bis(diazoylphosphino)ethanes 1 - 9: i) neat 1-methyl-2-TMS-imidazole; ii) 1. DEM-
imidazole, n-BuLi, thf, -78 °C, 2. H2O / acetone; iii) 1-methylbenzimidazole, n-BuLi, thf, -78 
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°C; iv) 5-bromoimidazole, EtMgBr, CH2Cl2; v) 1-DEM-2-isopropylimidazole, n-BuLi, thf, -
78 °C, 2. H2O / acetone; vi) thiazole, n-BuLi, thf, - 78 °C; vii) benzothiazole, n-BuLi, thf, -78 
°C; viii) benzothiazole, n-BuLi, thf, -78 °C; viii) 4-bromothiazole, EtMgBr, CH2Cl2; ix) 5-
bromothiazole, EtMgBr, CH2Cl2. 
For the synthesis of 4, which is a regioisomer of 2, a different approach had to be taken. Prior 
to forming the P-C bonds a halogen-metal exchange was carried out.[19] Therefore,5-bromo-
1-methylimidazole was reacted in dichloromethane with ethyl magnesium bromide and the 
resulting Grignard component reacted with bis(dichlorophosphino)ethane to give ligand 4. 
The three isomeric thiazole ligands 6, 8 and 9 were prepared in a similar manner. Ligand 6 
was prepared by direct lithiation of thiazole, where as ligands 8 and 9 were prepared via 
metal-halogen exchange of the corresponding 4- and 5-bromothiazole. The benzimidazole 
ligand 3 and the benzothiazole ligand 7 have been reported previously by Richards and Al-
Dulaymmi in the preparation of different metal complexes. However, the syntheses of the 
ligands were not mentioned and the ligands themselves not characterised.[20-22] 
The compounds 1 – 9 are potent chelating ligands as can be already seen in the MALDI mass 
spectra of these ligands. Besides the molecular ion and characteristic fragments, copper 
complexes are observed. The source of the copper is unknown, but seems to be the probe slit 
of the mass spectrometer. All ligands were characterised by 1H, 13C{1H} and 31P{1H} NMR 
spectroscopy (data summarised in Tables 1 and 2). Structural assignments were achieved with 
the help of a combination of 2D NMR experiments and by comparison of 1H NMR data with 
those reported previously for analogous phosphanes. The signal of the protons of the ethylene 
bridge appears as a deceptively simple triplet[21] in the region of 2.1 to 3.1 ppm (Table 1). 
 
*** PUT TABLE 1 HERE *** 
*** PUT TABLE 2 HERE *** 
 
The signals of the methylene bridge in the 13C{1H} NMR spectra are split due to the coupling 
with the two phosphorous atoms. For each carbon atom a second order system AA‘X results. 
Furthermore, for the CH carbon atoms in the thiazole ring of 6 and the CH carbon atoms in 
the benzothiazole substituents in 7 assignments of specific signals could not be accomplished 
on the basis of H,C-Cosy, HMBC and HMQC NMR and thus remain ambiguous. 
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In the case of the reactions to the three isomeric thiazole ligands different reaction products 
were obtained, as can be easily seen from the different resonances in the 31P{1H} NMR 
spectra. The unambiguous assignment to the thiazol-2-yl, 4-yl and 5-yl ligands 6, 8 and 9 was 
not possible based upon the spectroscopic data, as during the course of the reaction 
isomerisation of the metallated thiazole moieties might have occurred.[23, 24] The final 
assignment of the 2-, 4- and 5-yl isomers to 6, 8 and 9 was achieved by determination of the 
solid-state structure of 6 and 9. However, the data of the structure of 6 was not sufficient for 
publication but clearly shows the 2-yl connectivity. 
 
2.1. Hydrophilic/Hydrophobic Balance 
The partition coefficients of the compounds were determined using the shake-flask method 
(Table 3). The coefficients of the highly hydrophobic benzylated compounds 3 and 7 could 
not be determined by this method. As expected, compound 5 with the isopropyl groups shows 
the lowest hydrophilicity of the imidazolyl based compounds. Interestingly, both N-
methylated imidazolyl compounds (2 and 4) seem to be more hydrophilic than 1 which bears 
no alkyl groups at the nitrogen atoms. Presumably, 1 can form hydrogen bonds towards 
solvent molecules e.g. n-octanol and these solvates are than more lipophilic than the structure 
of 1 might suggest. The logD7.4 values for the three isomeric 2-, 4- and 5-yl thiazoles 6, 8 and 
9 are within the range of 0.6 to 1.0 and therefore are less hydrophilic than the isomeric 
imidazols 2 and 4. 
 
*** PUT TABLE 3 HERE *** 
 
In order to validate the logD values determined by UV/Vis spectroscopy we measured the 
partition coefficient of a sample of 2 by 31P NMR spectroscopy. Compound 2 was dissolved 
in n-octanol/PBS buffer and both phases were measured using a glass inlet tube with PPh3 as 
internal standard. To ensure that no nuclear Overhauser effect was observed we used standard 
inverse gated decoupling and additional delay time of 10 s for complete relaxation of the 
nuclei. Here, the logD value was determined to -0.76 ± 0.06 which is in good agreement with 
the value determined by UV/Vis spectroscopy. 
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2.2. Solid State Structures 
Crystals for X-ray analysis were grown by vapour diffusion. During the crystallisation 
process 7 was oxidised to the corresponding diphosphane dioxide 7a. The crystallographic 
data for 2, 3, 9 and 7a are summarised in Table 4. Tables with all angles and bond lengths can 
be found in the supporting information. The metric parameters are within the range found in 
diphos ligands.[24, 25] In all structures, the asymmetric unit contains only half of the 
corresponding ligand. The other half is either generated by a 42 symmetry element (for 2) or 
an inversion centre (for all other structures) respectively. 
 
*** PUT FIGURE 2 HERE *** 
Figure 2: Molecular structure of 2. The displacement ellipsoids are shown on a 50 % level 
and hydrogen atoms are omitted for clarity. 
 
*** PUT FIGURE 3 HERE *** 
Figure 3: Molecular structure of 3. The displacement ellipsoids are shown on a 50 % level 
and hydrogen atoms are omitted for clarity. 
 
*** PUT FIGURE 4 HERE *** 
Figure 4: Molecular structure of the dioxide of 7 (7a). The displacement ellipsoids are shown 
on a 50 % level. Hydrogen atoms and solvent molecules are omitted for clarity. 
 
*** PUT FIGURE 5 HERE *** 
Figure 5: Molecular structure of 9. The displacement ellipsoids are shown on a 50 % level 
and hydrogen atoms are omitted for clarity. 
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The reaction of 3 with [{(CO)2RhCl}2] in chloroform did not yield a ligand-stabilized 
rhodium carbonyl complex, as was seen by the missing carbonyl bands in the IR spectrum. 
Oxidation occurred to a binuclear rhodium(II) complex of the composition [(2)2Rh2Cl2]Cl2 
(10). We were able to obtain red crystals of 10 as solvate (Figure 6). In the cation, each 
rhodium carries a ligand 2 chelating through the phosphorus atoms, and a imidazolyl group 
from each phosphorus ligates the second rhodium through nitrogen, to give a ‘Double-A-
Frame’ geometry and the Rh-Rh distance of 2.6626(3) Å is within the range associated with a 
Rh-Rh single-bond. Such a ‘Double-A-Frame’ geometry is also observed in analogues 
compounds of 7.[20, 22] 
 
*** PUT FIGURE 6 HERE *** 
Figure 6: Molecular structure of 10·C4H8O·½C2H5OH. Displacement ellipsoids are shown on 
a 50 % level. The counter-ions, solvent molecules and hydrogen atoms are omitted for clarity. 
 
*** PUT TABLE 4 HERE *** 
 
Conclusion 
We presented a variety of isomeric new imidazole and thiazole based bisphosphanes are 
accessible. The hydrophilic/hydrobobic balance of such diphos-type ligands can be addressed 
by the nature and the connectivity of the azole substituents. Due to the topology of the donor-
atoms in the azole substituents these ligands should display a plethora of coordination modes. 
The availability of these ligands should be useful for investigation of new organometallic 
reagents for use in aqueous and biphasic catalysis as well as in bioorganometallic chemistry. 
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3. Experimental Section 
The compounds 1-diethoxymethylimidazol,[18] 1-diethoxymethyl-2-isopropylimidazole,[17] 
1-methyl-2-trimethylsilyimidazole and bis(dichlorphosphino)ethane[14] were prepared 
according to literature procedures. All preparations were carried out in Schlenk tubes under an 
atmosphere of dry nitrogen using anhydrous solvents purified according to standard 
procedures. All chemicals were used as purchased. NMR spectra were recorded on a Bruker 
DRX 200 or Bruker DRX 500 spectrometer. The 1H and 13C NMR spectra were calibrated 
against the residual proton signals and the carbon signals of the solvents as internal references 
([D1]chloroform: δH = 7.24 ppm and δC = 77.0 ppm; [D4]methanol: δH = 3.31 ppm and δC = 
49.1 ppm) while the 31P{1H} NMR spectra were referenced to external 85 % H3PO4. Infrared 
spectra were recorded with a Bruker IFS 66 FT-IR spectrometer. Time-of-flight mass spectra 
were recorded on a Bruker Ultraflex TOF, ESI mass spectra on an ion-trap mass spectrometer 
Finnigan LCQ Deca and EI mass spectra on a GC/MS-system Thermo Finnigan Trace DSQ. 
 
3.1. Synthesis of bis(diimidazol-2-ylphosphino)ethane, 2-dimpe (1) 
A solution of n-butyl lithium in hexane (1.6 M, 15 mL, 24 mmol) was added drop-wise to a 
solution of 3.7 g (22 mmol) of 1-diethoxymethylimidazole in diethyl ether (300 mL) at -78 
°C. The reaction mixture was stirred at –40 °C for 1 hour and at ambient temperature for 2 
hours. The reaction mixture was cooled to –78 °C and bis(dichlorophosphino)ethane (1.00 g, 
4.31 mmol) was added. The reaction mixture was stirred at ambient temperature over night. 
The precipitate was removed by filtration and the filtrate was concentrated in vacuo. The 
resulting orange oil was dissolved in CHCl3 (200 mL) and 2 mL of ammonia solution added. 
The organic phase was collected and all volatiles were removed in vacuo. The oily residue 
was dissolved in 100 mL acetone/water (10 : 1) and stirred at ambient temperature for 72 
hours. After cooling in an iced bath, the resulting precipitated was collected by filtration and 
dried in vacuo. Yield 0.97 g (63 %). 1H-NMR (200 MHz, 296 K, MeOD-d4): δ / ppm = 2,30 
(t, 4 H , (CH2)2 ), 7,22 (s, 8 H, Him). 1H-NMR (500 MHz, 296 K, dmso-d6): δ / ppm = 2,20 (t, 
4 H , (CH2)2 ), 7.20-7.25 (m, 8 H, Him), 12.57 (s, 4 H, NH). 13C{1H}-NMR (125 MHz, 296 K, 
dmso-d6): δ / ppm = 22.6 ((CH2)2), 124.9 (broad, C2), 143.1 (C4, C5). 31P{1H}-NMR (81 MHz, 
296 K, MeOD-d4): δ / ppm= - 50 (s). 31P{1H}-NMR (81 MHz, 296 K, dmso-d6): δ / ppm = - 
49 (s). EI MS (Pt, 210 °C): m/z (%) = 68 (100) ([C3H4N2]+), 222 (4.7) ([M-2im]+), 290 (1.3) 
([M-im]+), 358 (0.4) ([M]+). C14H16N8P2.CH3OH.H2O (408.13): calcd. C 45.1, H 5.3, N 28.1; 
found C 45.4, H 5.4, N 28.5. 
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3. 2. Synthesis of bis(di-1-methylimidazol-2-ylphosphino)ethane, 2-dimpeNMe (2) 
Bis(dichlorophosphino)ethane (635 mg, 2.74 mmol) was added drop-wise to 2.1 g (14 mmol) 
of neat 1-methyl-2-trimethylsilylimidazole at 0 °C. The reaction mixture was stirred for 14 h 
at ambient temperature. All volatiles were removed in vacuo. The residue was washed several 
times with n-hexane and dried in vacuo to yield 0.73 g (76 %) of a white solid. 1H-NMR (200 
MHz, 296 K, MeOD-d4): δ / ppm = 2,62 (t, 4 H, (CH2)2), 3,63 (s, 12 H, NMe ), 7,12 (s, 4 H, 
H4), 7,26 (s, 4 H, H5). 13C{1H}-NMR (125 MHz, 296 K, MeOD-d4): δ / ppm = 21.7 ((CH2)2), 
35.0 (NCH3), 127.1 (C5), 129.5 (C4), 144.1 (C2). 31P{1H}-NMR (81 MHz, 296 K, MeOD-d4): 
δ / ppm= - 54 (s). ESI+ (MeOH): m/z = 333.3 [M-imNMe]+, 415.3 [M+H]+, 437.4 [M+Na]+. 
C18H24N8P2.2H2O (450.41): calcd. C 48.0, N 6.3, H 24.9; found C 48.1, H 6.0, N 24.3. 
 
3. 3. Synthesis of bis(di-1-methylbenzimidazol-2-ylphosphino)ethane, 2-dbimpeNMe (3) 
A solution of n-butyl lithium in hexane (1.6 M, 6.3 mL) was added drop-wise to a solution of 
1-methylbenzimidazol (1.44 g) in toluene at –78 °C. The reaction mixture was stirred for 2 h 
and then bis(dichlorophosphino)ethane (500 mg, 0.32 mL) was added, the solution stirred for 
another hour at –78°C and over night at ambient temperature. Concentrated ammonia solution 
(5 mL) was added, the phases separated and the organic layer dried over Na2SO4. The 
volatiles were removed in vacuo to yield a slightly yellow solid, which was crystallised from 
methanol / toluene. Yield (80 %). 1H-NMR (200 MHz, 296 K, CDCl3): δ / ppm = 3.09 (t, 4H, 
(CH2)2), 3.72 (s, 12H, NCH3), 7.16 – 7.31 (m, 12H, bzim), 7.63 – 7.75 (m, 4H, bzim). 
13C{1H}-NMR (125 MHz, 296 K, CDCl3): δ / ppm = 21.0, 29.5, 109.9, 120.5, 122.8, 123.8, 
161.3. 31P{1H}-NMR (81 MHz, 296 K, CDCl3): δ / ppm = - 45 (s). MALDI TOF (DIT, 
CHCl3): m/z = 483.1 [M-C8H7N2]+, 615.2 [M]+, 647.2 [M+O]+, 677.9 [M+Cu]+. 
C34H32N8P2.6MeOH (806.88): calcd. C 59.5, H 6.9, N 13.9; found C 59.9, H 6.3, N 13.5. 
 
 
3. 4. Synthesis of bis(di-1-methylimidazol-5-ylphosphino)ethane, 5-dimpeNMe (4) 
To a solution of 5-bromo-1-methylimidazole (2.13 g, 13.2 mmol) in 20 mL of 
dichloromethane 4.4 mL of ethylmagnesium bromide in diethyl ether (3.0 M, 4.4 mL, 13.2 
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mmol) were added at ambient temperature. The solution was stirred for 1 hour at ambient 
temperature, then bis(dichlorophosphino)ethane (0.4 mL, 2.6 mmol) in dichloromethane (10 
mL) was added drop-wise. The suspension was stirred over night, then a brine solution (5 
mL) added and the organic layer extracted with bidest. water (3 x 10 mL) and dried over 
Na2SO4. After filtration and evaporation the residue was stirred in n-hexane, the white 
precipitate isolated by filtration and dissolved in methanol. After filtration, n-hexane was 
added to the clear filtrate and the precipitate dried in vacuo to yield 0.57 g (62 %) of a white 
solid. 1H-NMR (500 MHz, 296 K, CDCl3): δ / ppm = 2,20 (t, 4 H, (CH2)2), 3,51 (s, 12 H, 
NMe ), 7,09 (s, 4 H, H4), 7,56 (s, 4 H, H2). 13C{1H}-NMR (125 MHz, 296 K, CDCl3): δ / ppm 
= 22.4 ((CH2)2), 332.8 (NCH3), 124.4 (C5), 1237.3 (C4), 142.3 (C2). 31P{1H}-NMR (81 MHz, 
296 K, CDCl3): δ / ppm= - 73 (s). MALDI TOF (DIT, CHCl3): m/z = 415.0 [M+H]+, 431.0 
[M+O+H]+. C18H24N8P2.2MeOH.H2O (450.41): calcd. C 48.4, H 6.9, N 22.6; found C 48.1, H 
6.3, N 22.3. 
 
3. 5. Synthesis of bis(di-2-isopropylimidazol-4(5)-ylphosphino)ethane, 4-dimpeiPr (5) 
To 1-diethoxymethyl-2-isopropylimidazol (2.3 g, 11 mmol) in thf (100 mL) was added tert-
butyl lithium in hexane (1.6 M, 6.9 mL, 11 mmol) at –78 °C. The solution was stirred at –78 
°C for 1 hour and then bis(dichlorophosphino)ethane (500 mg, 0.32 mL, 2.2 mmol) added. 
The reaction mixture was stirred over night at ambient temperature, ammonia solution (3 mL) 
added and concentrated in vacuo to 20 mL. Dichloromethane (100 mL) was added and the 
organic phase extracted with brine. The organic layer was separated, all volatiles removed in 
vacuo, 100 mL acetone / water (10 : 1) added and the solution stirred at ambient temperature 
over night. The resulting white precipitate was filtered, washed with acetone and dried in 
vacuo to yield 0.48 g (42 %) of the product. 1H-NMR (200 MHz, 296 K, MeOD-d4): δ / ppm 
= 1.28 (d, J = 7.0 Hz, 24H, CH(CH3)2), 2.03(t, 4 H , (CH2)2), 3.04 (sept., J = 7.0 Hz, 4H, 
CH(CH3)2),7.00 (s, 4H, H4(5)). 13C{1H}-NMR (125 MHz, 296 K, MeOD-d4): δ / ppm = 20.5 
(CH3), 28.2 (CH2), 48 (CH), 130.1 (C4(5)), 153.7 (C5(4)), 157.7 (C2). 31P{1H}-NMR (81 MHz, 
296 K, MeOD-d4): δ / ppm= - 63 (s). ESI+ (MeOH): m/z = 417.5 [M-imiPr]+, 527.5 [M+H]+. 
C26H40N8P2.1/2C3H6O.3/2H2O (582.32): cald. C 56.7, H 8.0, N 19.2; found C 56.4, H 7.6, N 
19.6. 
 
3. 6. Synthesis of bis(dithiazol-2-ylphosphino)ethane, 2-dthiape (6) 
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A solution of thiazole (930 mg, 0.78 mL) in 100 mL of toluene was cooled to –78 °C and 6.3 
mL n-butyl lithium in hexanes (1.6 M) were added. The solution was stirred at –78 °C for 2 h 
and then bis(dichlorophosphino)ethane (500 mg, 0.32 mL, 2.2 mmol) was added, the solution 
stirred for another hour at –78°C and over night at ambient temperature. Concentrated 
ammonia solution (5 mL) was added, the phases separated and the organic layer dried over 
Na2SO4. The volatiles were removed in vacuo to yield a slightly yellow solid. After solution 
in methanol, the product was precipitated upon addition of diethyl ether and dried in vacuo to 
yield 0.58 g (62 %) of a white solid. 1H-NMR (200 MHz, 296 K, CDCl3): δ / ppm = 2.73 (t, 4 
H , (CH2)2), 7.58 (d, 4H, J = 3.0 Hz, H4/5), 8.06 (d, 4H, J = 3.0 Hz, H4/5). 13C{1H}-NMR (125 
MHz, 296 K, CDCl3): δ / ppm = 25.7 ((CH2)2), 123.8 (C4/5), 145.6 (C4/5), 167.9 (C2). 31P{1H}-
NMR (81 MHz, 296 K, CDCl3): δ / ppm = - 23 (s). ESI+ (MeOH): m/z = 342.3 [M-C3H2NS]+, 
427.1 [M+H]+, 449.3 [M+Na]+. C14H12N4P2S4.CH3OH (457.97): calcd. C 39.3, H 3.5, N 12.2; 
found C 39.2, H 3.3, N 11.9. 
 
3. 7. Synthesis of Bis(dibenzothiazol-2-yl)ethane,2-dbthiape (7) 
Benzothiazole (1.13 mL, 10.0 mmol) in thf (100 mL were treated with n-butyl lithium (1.6 M 
in hexane, 6.3 mL, 10.0 mmol) at –78 °C. The deep red solution was stirred at –78 °C for 90 
minutes and then bis(dichlorophosphino)ethane (500 mg, 0.32 mL, 2.2 mmol) was added, the 
solution stirred for another hour at –78°C and over night at ambient temperature. Ammonia 
solution was added (20 mL), stirred and the suspension concentrated to about 80 mL in vacuo. 
The precipitate was filtered, washed with water (100 mL) and ethyl ether (100 mL) and dried 
in vacuo. Yield 1.09 g (78 %). 1H-NMR (200 MHz, 296 K, CDCl3): δ / ppm = 3.01 (t, 4H , 
(CH2)2), 7.30 – 7.59 (m, 8H), 7.78 – 7.85 (m, 4H), 8.02 – 8.10 (m, 4H). 13C{1H}-NMR (125 
MHz, 296 K, CDCl3): δ / ppm = 25.0, 121.8, 124.0, 126.0, 126.5, 137.3, 155.0. 31P{1H}-NMR 
(81 MHz, 296 K, CDCl3): δ / ppm = - 15 (s). MALDI TOF (DIT, CHCl3): m/z = 626.9 [M]+, 
642.0 [M+O]+, 658.9 [M+2O+H]+, 688.9 [M+Cu]+. C30H20N4P2S4.H2O (644.01): calcd. C 
55.9, H 3.4, N 8.7; found C 56.1, H 3.4, N 8.6. 
 
3. 8. Synthesis of bis(dithiazol-4-ylphosphino)ethane, 4-dthiape (8) 
To a solution of 4-bromothiazole (1 g, 6 mmol) in dichloromethane (200 mL) a solution of 
ethylmagnesium bromide in diethyl ether (3.0 M, 2.03 mL, 6.1 mmol) was added. The 
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solution was stirred for 1.5 hours at ambient temperature, then bis(dichlorophosphino)ethane 
(0.2 mL, 1.3 mmol) in dichloromethane (10 mL) was added drop wise and the suspension 
stirred over night. The mixture was quenched by addition of conc. ammonia (25 %, 5 mL) and 
brine (10 mL). The organic solvents were removed in vacuo, the precipitate was removed by 
filtration, washed wit bidest. water and diethyl ether and the off-white solid dried in vacuo. 
The solid was dissolved in dichloromethane (50 mL), died over Na2SO4, and after filtration 
and concentration in vacuo the product was precipitated upon addition of diethyl ether. Yield 
0.36 g (65 %). 1H-NMR (200 MHz, 296 K, CDCl3): δ / ppm = 2.64 (t, 4 H , (CH2)2), 7.44 (m, 
4H). 13C{1H}-NMR (125 MHz, 296 K, CDCl3): δ / ppm = 25.4 ((CH2)2), 122.3 (C2), 128.0 
(C5), 168.2 (C4). 31P{1H}-NMR (81 MHz, 296 K, CDCl3): δ / ppm = - 19 (s). EI MS (Pt, 200 
°C): m/z (%) = 426 (10.6) [M]+. C30H20N4P2S4.3.5CHCl3 (838.65): calcd. C 24.9, H 1.9, N 
6.6; found C 25.2, H 1.7, N 6.9. 
 
3. 9. Synthesis of bis(dithiazol-5-ylphosphino)ethane, 5-dthiape (9) 
To a solution of 5-bromothiazole (0.96 g, 5.7 mmol) in dichloromethane (100 mL) a solution 
of ethylmagnesium bromide in diethyl ether (3.0 M, 2.01 mL, 5.7 mmol) was added. The 
solution was stirred for 1.5 hours at ambient temperature, then bis(dichlorophosphino)ethane 
(0.27 g, 1.2 mmol) in dichloromethane (10 mL) was added drop-wise and the suspension 
stirred over night. The mixture was quenched by addition of conc. ammonia (25 %, 5 mL). 
The mixture was filtered through a plug of Celite, the organic layer extracted with bidest. 
water and the aqueous layer with dichloromethane. The combined organic layers were dried 
over Na2SO4, and after filtration and all volatiles were removed in vacuo. The product was 
washed with bidest. water and diethyl ether and dried in vacuo. Yield 0.35 g (58 %). 1H-NMR 
(200 MHz, 296 K, CDCl3): δ / ppm = 2.15 (t, 4 H , (CH2)2), 8.04 (m, 4H), 9.01 (s, 4H). 
13C{1H}-NMR (125 MHz, 296 K, CDCl3): δ / ppm = 28.5 ((CH2)2), 132.5 (C5), 151.0 (C4), 
159.0 (C2). 31P{1H}-NMR (81 MHz, 296 K, CDCl3): δ / ppm = - 52 (s). EI MS (Pt, 210 °C): 
m/z (%) = 426 (2.4) [M]+. C30H20N4P2S4.H2O (443.95): calcd. C 37.8, H 3.2, N 12.6; found C 
38.2, H 3.3, N 12.1. 
 
3.10 Synthesis of [(2)2Rh2Cl2]Cl2 (10) 
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[{(CO)2RhCl}2] (30 mg, 77 µmol) was added to a solution of 2 (63.9 mg, 154 µmol) in 
CHCl3. The solution was stirred at ambient temperature for 1.5 hours. The volume was 
concentrated to one third, then n-hexane added. The resulting red precipitate removed by 
centrifugation, washed with n-hexane and dried in vacuo. Yield 19 mg, 21 %. Crystals were 
grown form EtOH / thf. 1H NMR (200 MHz, 296 K, MeOD-d4): δ / ppm = 2.47 (m, 4H, CH2, 
broad), 3.79 (s, 12H, NCH3 broad), 7.17 (s, 4H, Him), 7.40 (s, 4H, Him), 7.45 (s, 4H, Him), 7.76 
(s, 4H, Him). 13C{1H} NMR (125 MHz, 296 K, MeOD-d4): δ / ppm = 25.0 ((CH2)2), 33.5 
(NCH3), 27.0 (Cim, 2 signals), 129.3 (Cim), 130.2 (Cim). 31P{1H} NMR (81 MHz, 296 K, 
MeOD-d4): δ / ppm = 34.0 ppm (d, J = 126 Hz). MALDI TOF (DIT, CHCl3): m/z = 1034.1 
[L2Rh2]+, 1069.1 [L2Rh2Cl]+, 1104.1 [L2Rh2Cl2]+. C36H48N16Cl4P4Rh2·CH2Cl2·4H2O 
(1333.40): calcd. C 33.3, H 4.4, N 16.8; found C 33.4, H 4.5, N 16.45. IR (KBr):  / cm-1 = 
3395 (s, broad), 3102 (m), 2956 (m), 1281 (m), 773 (m), 565 (s), 513 (m). 
 
4. Measurement of lipophilicity (logD) 
The n-octanol–water partition coefficients of the compounds 1 - 9 were determined using a 
shake-flask method. PBS buffered bi-destillated water (100 mL, phosphate buffer, c(PO43-) = 
10 mM, c(NaCl) = 0.15 M, pH adjusted to 7.4 with HCl) and n-octanol (100 mL) were shaken 
together using a laboratory shaker (Perkin-Elmer), for 72 h to allow saturation of both phases. 
1 mg of each compound was mixed in 1 mL of aqueous and organic phase, respectively for 10 
minutes using a laboratory vortexer. The resultant emulsion was centrifuged (3000 × g, 5 
min) to separate the phases. The concentrations of the compounds in the organic and aqueous 
phases were then determined using UV absorbance spectroscopy (230 nm). LogDpH was 
defined as the logarithm of the ratio of the concentrations of the complex in the organic and 
aqueous phases (logD = log{[diphos(org)]/[diphos(aq)]}; the value reported is the mean of three 
separate determinations. 
 
5. Crystallographic Studies 
Crystallographic data were collected at 183(2) K on an Oxford Diffraction Xcalibur system 
with a Ruby detector using Mo Kα radiation (λ = 0.7107 Å) that was graphite-
monochromated. Suitable crystals were covered with oil (Infineum V8512, formerly known 
as Paratone N), mounted on top of a glass fibre and immediately transferred to the 
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diffractometer. The program suite CrysAlisPro was used for data collection, semi-empirical 
absorption correction and data reduction.[26] Structures were solved with direct methods 
using SIR97[27] and were refined by full-matrix least-squares methods on F2 with SHELXL-
97.[28] The structures were checked for higher symmetry with help of the program 
Platon.[29] A disordered THF molecule was found in 10·C4H8O·½C2H5OH, the two 
orientations were refined with a ratio of 6:4. In addition a half occupied ethanol molecule near 
a centre of inversion was found. In both cases, appropriate restraints were applied. 
Crystallographic data (excluding structure factors) has been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication Nos. CCDC 773467 - 773471. 
Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, 
Cambridge, CB2 1EZ, UK [Fax: +44 (1223)336 033; E-mail: deposit@ccdc.cam.ac.uk. 
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Table 1: 31P{1H} and 1H chemical shifts (δ / ppm) of diphos-type ligands. 
Ligand R δ(31P{1H}) / ppm δ(1H) / ppm 
      -C2H4- other signals 
1 Imidazol-2-yl - 50 2.30 7.22 
2 1-Methylimidazol-2-yl - 54 2.62 3.63, 7.12, 7.26 
3 1-Methyl-benzimidazol-2-yl - 45 3.09 3.72, 7.16 – 7.31, 
7.63 – 7.75 
4 1-Methylimidazol-5-yl -73 2.20 7.09, 7.56 
5 2-Isopropylimidazol-4(5)-yl - 63 2.03 1.28, 3.04, 7.00 
6 Thiazol-2-yl - 20 2.73 7.58, 8.06 
7 Benzothiazol-2-yl - 15 3.01 7.30 – 7.59, 7.78 – 
7.85, 8.02 – 8.10 
8 Thiazol-4-yl - 19 2.64 7.44 
9 Thiazol-5-yl - 52 2.15 8.04, 9.01 
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Table 2: 13C{1H} chemical shifts (δ / ppm) of diphos-type ligands. 
Ligand R δ(13C{1H}) / ppm 
    -C2H4- other signals 
1 Imidazol-2-yl 22.6 124.9, 143.1 
2 1-Methylimidazol-2-yl 21.7 35.0 (NCH3), 127.1 (C5), 129.5 (C4), 
144.1 
3 1-Methyl-benzimidazol-2-yl 21.0 29.5, 109.9, 120.5, 122.8, 123.8, 161.3
4 1-Methylimidazol-5-yl 22.4 32.8 (NCH3), 124.4 (C2), 137.3 (C4), 
142.3 (C5) 
5 2-Isopropylimidazol-4(5)-yl 28.2 20.5 (CH3), 48 (CH), 130.1 (C4(5)), 
153.7 (C5(4)), 157.7 (C2). 
6 Thiazol-2-yl 25.7 123.8 (C4/5), 145.6 (C4/5), 167.9 (C2) 
7 Benzothiazol-2-yl 25.0 121.8, 124.0, 126.0, 126.5, 137.3, 155.0
8 Thiazol-4-yl 25.4 122.3 (C2), 128.0 (C5), 168.2 (C4) 
9 Thiazol-5-yl 28.5 132.5 (C5), 151.0 (C4), 159.0 (C2) 
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Table 3: LogD7.4 values and standard deviation determined via the shake-flask method. 
Ligand R logD7.4 (exp.) 
1 Imidazol-2-yl 0.19 ± 0.07 
2 1-Methylimidazol-2-yl -0.73 ± 0.03 
3 1-Methyl-benzimidazol-2-yl n.d. 
4 1-Methylimidazol-5-yl -0.02 ± 0.05 
5 2-Isopropylimidazol-4(5)-yl 0.85 ± 0.04 
6 Thiazol-2-yl 0.73 ± 0.01 
7 Benzothiazol-2-yl n.d. 
8 Thiazol-4-yl 0.61 ± 0.05 
9 Thiazol-5-yl 0.97 ± 0.07 
 
n.d. not determined due to low solubility in water and/or n-octanol. 
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Table 4: Crystallographic data for compounds 2, 3, 7a·(C5H10)2, 9 and 10·C4H8O·½C2H5OH. 
 2 3 7a·(C5H10)2 9 10·C4H8O·½C2H5OH 
Formula C18H24N8P2 C34H32N8P2 C40H40N4O2P2S4 C14H12N4P2S4 C46H70Cl4N16O3P4Rh2 
M (g mol-1) 414.39 614.62 798.94 426.46 1366.68 
Crystal system Tetragonal Monoclinic Triclinic Triclinic Monoclinic 
Space group P42 P21/c P-1 P-1 C2/c 
a(Å) 12.5078(3) 9.0807(2) 9.7003(3) 5.6563(6) 25.3183(3)  
b(Å) 12.5078(3) 10.4579(2) 10.3399(2) 8.4971(9) 16.88021(16)  
c(Å) 6.7689(2) 15.9180(3) 10.6682(3) 10.1074(9) 13.51874(12)  
(°)   98.5494(19) 104.719(8)  
β(°)  91.494(2) 108.157(2) 102.660(8) 102.903(1) 
(°)   97.012(2) 93.637(8)  
V(Å3) 1058.96(5) 1511.14(5)  989.17(4) 454.75(8)  5631.7(1)  
Z 2 2 1 1 4 
Dc calc (g.cm-3) 1.300 1.351 1.341 1.557 1.612 
Linear absorption 
coefficient (mm-1) 
0.226 0.184 0.362 0.703  0.946 
Crystal size  0.19 x 0.14 x 
0.06 
0.62 x 0.25 
x 0.19 
0.41 x 0.30 x 
0.25 
0.36 x 0.14 x 
0.05 
0.37 x 0.32 x 0.25  
Crystal 
description 
colourless 
plate 
colourless 
prism 
colourless prism colourless 
plate 
light pink block 
Measured 
reflections 
6350 19990 27475 10020 63619 
Unique 
reflections/Rint 
2164 / 
0.0489 
5749 / 
0.0311 
7535 / 0.0229 2758 / 0.0298 10732 / 0.0307 
Observed 
reflections  
1369 3779 6021 2098 8491 
Completeness to 
theta 
99.7 % / 
26.37° 
99.9 % / 
33.14° 
100.0 % / 33.14° 100.0 % / 
30.50° 
100.0 % / 33.14° 
Max. and min. 
transmission 
0.9865 / 
0.9451 
0.9659 / 
0.8955 
0.9150 / 0.8727 0.9657 / 
0.8587 
0.7981 / 0.7803 
Refined 
parameters 
/restraints 
129 / 1 203 / 0 235 / 0 109 / 0 338 / 12 
GooF 0.962 0.966 1.064 1.027 1.069 
R1(F) / wR2 (F2) 
[I>2σ(I)] 
0.0598 / 
0.1220 
0.0579 / 
0.1397 
0.0447 7 0.1353 0.0372 / 
0.0932 
0.0373 / 0.1122 
R1(F) / wR2 (F2) 
(all data) 
0.1074 / 
0.1334 
0.0945 / 
0.1534 
0.0555 / 0.1400 0.0572 / 
0.0983 
0.0509 / 0.1172 
Flack parameter -0.1(2)     
Largest diff. peak 
and hole (eÅ-3) 
0.680 / -
0.202 
0.611 / -
0.221 
0.785 / -0.452 0.720 / -0.289 1.142 / -0.724 
 
 
 
